Communicable Diseases Surveillance: Additional reports

This report contains quarterly reports and data from a number of disease surveillance programs which report regularly to CDI.

Page last updated: 22 August 2011

Australian Sentinel Practices Research Network

The Australian Sentinel Practices Research Network (ASPREN) is a national surveillance system that is funded by the Commonwealth’s Department of Health and Ageing, owned and operated by the Royal Australian College of General Practitioners and directed through the Discipline of General Practice at the University of Adelaide.

The network consists of general practitioners who report presentations on a number of defined medical conditions each week. ASPREN was established in 1991 to provide a rapid monitoring scheme for infectious diseases that can alert public health officials of epidemics in their early stages as well as play a role in the evaluation of public health campaigns and research of conditions commonly seen in general practice. Electronic, web-based data collection was established in 2006.

In June 2010, ASPREN’s laboratory ILI testing was implemented, allowing for viral testing of 25% of ILI patients for a range of respiratory viruses including influenza A, influenza B and H2N1(2009).

The list of conditions is reviewed annually by the ASPREN management committee. In 2011, 4 conditions are being monitored. They include influenza-like illness (ILI), gastroenteritis and varicella infections (chickenpox and shingles). Definitions of these conditions are described in Surveillance systems reported in CDI, published in Commun Dis Intell 2011;35(1):57–58.

Reporting period 1 January to 31 March 2011

Sentinel practices contributing to ASPREN were located in all 8 jurisdictions in Australia. A total of 102 general practitioners contributed data to ASPREN in the 1st quarter of 2011. Each week an average of 94 general practitioners provided information to ASPREN at an average of 8,125 (range 3,872–9,362) consultations per week and an average of 105 (range 60–133) notifications per week.

ILI rates reported from 1 January to 31 March 2011 averaged 5 cases per 1,000 consultations (range 3–7 cases per 1,000 consultations). The reported rates in January, February and March 2011 (3–6 cases per 1,000 consultations, 5–6 cases per 1,000 consultations and 6–7 cases per 1,000 consultations respectively) were relatively consistent compared with rates in the same reporting period in 2010 (1–9 cases per 1,000 consultations, 4–5 cases per 1,000 consultations and 5–6 cases per 1,000 consultations, respectively).

Figure 1: Consultation rates for influenza-like illness, ASPREN, 1 January 2010 to 31 March 2011, by week of report

Figure 1:  Consultation rates for influenza-like illness, ASPREN, 1 January 2010 to 31 March 2011, by week of report

Top of page

ILI swab testing has continued through 2011. The most commonly reported virus during this reporting period was rhinovirus (27% of all swabs performed), with the second most common virus being influenza A H2N1(2009) (12% of all swabs performed).

From the beginning of 2011 to the end of week 13, 21 cases of influenza have been detected, the majority of these being H2N1(2009) (12% of all swabs performed) and the remainder were influenza A untyped or other (4%) and influenza B (2%) (Figure 2).

Figure 2: Influenza-like illness swab testing results, ASPREN, 1 January 2010 to 31 March 011, by week of report

Figure 2:  Influenza-like illness swab testing results, ASPREN, 1 January 2010 to 31 March 011, by week of report

Top of page

During this reporting period, consultation rates for gastroenteritis averaged 6 cases per 1,000 consultations (range 5–7 cases per 1000, Figure 3). This was relatively consistent compared with rates in the same reporting period in 2010 where the average was 6 cases per 1,000 consultations (range 4–13 cases per 1,000).

Figure 3: Consultation rates for gastroenteritis, ASPREN, 1 January 2010 to 31 March 2011, by week of report

Figure 3:  Consultation rates for gastroenteritis, ASPREN, 1 January 2010 to 31 March 2011, by week of report

Top of page

Varicella infections were reported at a slightly higher rate for the 1st quarter of 2011 compared with the same period in 2010. From 1 January to 31 March 2011, recorded rates for chickenpox averaged 0.3 cases per 1,000 consultations (range 0.1 to 0.8 cases per 1,000 consultations, Figure 4).

Figure 4: Consultation rates for chickenpox, ASPREN, 1 January 2010 to 31 March 2011, by week of report

Figure 4:  Consultation rates for chickenpox, ASPREN, 1 January 2010 to 31 March 2011, by week of report

Top of page

In the 1st quarter of 2011, reported rates for shingles averaged 1.1 cases per 1,000 consultations (range 0.4–1.8 cases per 1,000 consultations, Figure 5), slightly higher than the same reporting period in 2010 where the average shingles rate was 0.9 cases per 1,000 consultations (0.2–1.9 cases per 1,000 consultations).

Figure 5: Consultation rates for shingles, ASPREN, 1 January 2010 to 31 March 2011, by week of report

Figure 5:  Consultation rates for shingles, ASPREN, 1 January 2010 to 31 March 2011, by week of report

Top of page

Meningococcal surveillance

(Dr Monica M Lahra, The Prince of Wales Hospital, Randwick, NSW, 2031 for the Australian Gonococcal Surveillance Programme)

The reference laboratories of the Australian Meningococcal Surveillance Programme report data on the number of cases confirmed by laboratory testing using culture and by non-culture based techniques. Culture positive cases, where Neisseria meningitidis is grown from a normally sterile site or skin lesions, and non-culture based diagnoses, derived from results of nucleic acid amplification assays (NAA) and serological techniques, are defined as invasive meningococcal disease (IMD) according to Public Health Laboratory Network definitions. Data contained in quarterly reports are restricted to a description of the numbers of cases by jurisdiction and serogroup, where known. Some minor corrections to data in the Table may be made in subsequent reports if additional data are received. A full analysis of laboratory confirmed cases of IMD in each calendar year is contained in the annual reports of the Programme is published in Communicable Diseases Intelligence. For more information see Commun Dis Intell 2011;35(1):57.

Laboratory confirmed cases of invasive meningococcal disease for the period 1 January to 31 March 2011, are included in this issue of Communicable Diseases Intelligence (Table 1).

Table: Number of laboratory confirmed cases of invasive meningococcal disease, Australia, 1 January to 31 March 2011, by serogroup and state or territory

  Serogroup
  A B C Y W135 ND All
State or territory
Year Q1 YTD Q1 YTD Q1 YTD Q1 YTD Q1 YTD Q1 YTD Q1 YTD
Australian Capital Territory
11
3
3
0
0
0
0
0
0
0
0
3
3
10
0
0
0
0
0
0
0
0
0
0
0
0
New South Wales
11
10
10
0
0
3
3
1
1
3
3
17
17
10
13
13
0
0
0
0
1
1
1
1
15
15
Northern Territory
11
0
0
0
0
0
0
0
0
0
0
0
0
10
0
0
0
0
0
0
0
0
0
0
0
0
Queensland
11
8
8
1
1
1
1
0
0
0
0
10
10
10
6
6
0
0
0
0
0
0
0
0
6
6
South Australia
11
3
3
0
0
0
0
1
1
0
0
4
4
10
4
4
0
0
1
1
0
0
0
0
5
5
Tasmania
11
0
0
1
1
0
0
1
1
0
0
2
2
10
0
0
0
0
0
0
0
0
0
0
0
0
Victoria
11
10
10
0
0
0
0
0
0
0
0
10
10
10
3
3
0
0
1
1
1
1
0
0
5
5
Western Australia
11
4
4
0
0
0
0
0
0
0
0
4
4
10
2
2
1
1
0
0
0
0
0
0
3
3
Total
11
38
38
2
1
4
4
3
3
3
3
50
50
10
28
28
1
1
2
2
2
2
1
1
34
34

Top of page

HIV and AIDS surveillance

National surveillance for HIV disease is coordinated by the Kirby Institute (formerly the National Centre in HIV Epidemiology and Clinical Research), in collaboration with state and territory health authorities and the Commonwealth of Australia. Cases of HIV infection are notified to the National HIV Registry on the first occasion of diagnosis in Australia, by either the diagnosing laboratory (Australian Capital Territory, New South Wales, Tasmania, Victoria) or by a combination of laboratory and doctor sources (Northern Territory, Queensland, South Australia, Western Australia). Cases of AIDS are notified through the state and territory health authorities to the National AIDS Registry. Diagnoses of both HIV infection and AIDS are notified with the person’s date of birth and name code, to minimise duplicate notifications while maintaining confidentiality.

Tabulations of diagnoses of HIV infection and AIDS are based on data available 3 months after the end of the reporting interval indicated, to allow for reporting delay and to incorporate newly available information. More detailed information on diagnoses of HIV infection and AIDS is published in the quarterly Australian HIV Surveillance Report, and annually in ‘HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia, annual surveillance report’. The reports are available from the Kirby Institute, CFI Building, Cnr Boundary and West Streets, Darlinghurst NSW 2010. Internet: http://hiv.cms.med.unsw.edu.au/ Telephone: +61 2 9385 0900. Facsimile: +61 2 9385 0920. For more information see Commun Dis Intell 2011;35(1):58.

HIV and AIDS diagnoses and deaths following AIDS reported for 1 January to 31 March 2010, and 1 April to 30 June 2010, are included in this issue of Communicable Diseases Intelligence (Tables 1, 2, 3 and 4).

Table 1: New diagnoses of HIV infection, new diagnoses of AIDS and deaths following AIDS occurring in the period 1 January to 31 March 2010, by sex and state or territory of diagnosis

    State or territory Totals for Australia
Sex
ACT NSW NT Qld SA Tas Vic WA This period 2010 This period 2009 YTD 2010 YTD 2009
HIV diagnoses
Female
0
8
0
19
2
0
7
0
36
41
36
41
Male
0
87
4
48
12
0
55
5
211
211
211
211
Not reported
0
1
0
0
0
0
2
0
3
0
3
0
Total*
0
97
4
67
14
0
64
5
251
252
251
252
AIDS diagnoses
Female
0
0
1
0
0
1
0
2
6
2
6
Male
0
2
3
1
0
8
0
14
21
14
21
Total*
0
2
4
1
0
9
0
16
27
16
27
AIDS deaths
Female
0
0
0
0
0
0
0
0
0
0
0
  Male
0
0
1
1
0
3
0
5
3
5
3
  Total*
0
0
1
1
0
3
0
5
3
5
3

* Totals include people whose sex was reported as transgender.

† AIDS cases and deaths following AIDS occurring in New South Wales from January 2008 are not included.

Top of page

Table 2: Number of new diagnoses of HIV infection since the introduction of HIV antibody testing 1985, and number of new diagnoses of AIDS and deaths following AIDS since 1981, cumulative to 31 March 2010, by sex and state or territory

    State or territory  
 
Sex
ACT NSW NT Qld SA Tas Vic WA Aust
HIV diagnoses
Female
37
1,018
30
374
127
17
472
266
2,341
Male
283
14,573
162
3,299
1,078
127
6,067
1,405
26,994
Not reported
0
229
0
0
0
0
22
0
251
Total*
320
15,853
192
3,682
1,206
144
6,585
1,678
29,660
AIDS diagnoses
Female
10
265
6
78
32
4
127
48
570
Male
95
5,513
50
1,101
427
55
2,162
458
9,861
Total*
105
5,796
56
1,181
460
59
2,302
508
10,467
AIDS deaths
Female
7
138
1
43
20
2
66
30
307
  Male
73
3,597
33
682
281
34
1,452
301
6,453
  Total*
80
3,746
34
727
301
36
1,527
332
6,783

* Totals include people whose sex was reported as transgender.

† AIDS cases and deaths following AIDS occurring in New South Wales from January 2008 are not included.

Top of page

Table 3: New diagnoses of HIV infection, new diagnoses of AIDS and deaths following AIDS occurring in the period 1 April to 30 June 2010, by sex and state or territory of diagnosis

    State or territory Totals for Australia
 
Sex
ACT NSW NT Qld SA Tas Vic WA This period 2010 This period 2009 YTD 2010 YTD 2009
HIV diagnoses
Female
1
5
0
7
2
0
9
8
32
35
71
76
Male
4
73
0
52
10
0
68
21
228
238
453
450
Not reported
0
0
0
0
0
0
0
0
0
1
1
1
Total*
5
78
0
59
12
0
77
29
260
274
528
527
AIDS diagnoses
Female
0
0
0
0
0
0
1
1
2
3
8
Male
0
0
5
0
0
9
1
15
23
30
44
Total*
0
0
5
0
0
9
2
16
25
33
52
AIDS deaths
Female
0
0
1
0
0
0
0
1
1
1
1
  Male
0
0
1
0
0
2
0
3
2
8
5
  Total*
0
0
2
0
0
2
0
4
3
9
6

* Totals include people whose sex was reported as transgender.

† AIDS cases and deaths following AIDS occurring in New South Wales from January 2008 are not included.

Top of page

Table 4: Number of new diagnoses of HIV infection since the introduction of HIV antibody testing 1985, and number of new diagnoses of AIDS and deaths following AIDS since 1981, cumulative to 30 June 2010, by sex and state or territory

    State or territory  
 
Sex
ACT NSW NT Qld SA Tas Vic WA Aust
HIV diagnoses
Female
38
1,025
30
381
129
17
481
281
2,382
Male
287
14,656
162
3,349
1,088
127
6,136
1,443
27,248
Not reported
0
228
0
0
0
0
22
0
250
Total*
325
15,942
192
3,739
1,218
144
6,663
1,731
29,954
AIDS diagnoses
Female
10
265
6
78
32
4
127
49
571
Male
95
5,513
50
1,106
427
55
2,171
461
9,878
Total*
105
5,796
56
1,186
460
59
2,311
512
10,485
AIDS deaths
Female
7
138
1
44
20
2
66
30
308
  Male
73
3,597
33
683
281
34
1,454
301
6,456
  Total*
80
3,746
34
729
301
36
1,529
332
6,787

* Totals include people whose sex was reported as transgender.

† AIDS cases and deaths following AIDS occurring in New South Wales from January 2008 are not included.